Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Combo: Protein & VLP vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2012-05-17 |
| Study Made Public: | 2013-03-21 |
Title
Lai_CAVD21
Description
CAVD 367 is a preclinical guinea pig study investigating Virus-Like Particles (VLP) (Env alone and ENV-Gag) derived from ZM96, in comparison to ZM96 gp140.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.